Steffen‐Sebastian Bolz
Agilent Technologies (United States)(US)University of Toronto(CA)Heart and Stroke Foundation(CA)Puerto Rico Department of Health(PR)Ted Rogers Centre for Heart Research(CA)Applied Pharma Research (Switzerland)(CH)Micropharma (Canada)(CA)
Publications by Year
Research Areas
Nitric Oxide and Endothelin Effects, Sphingolipid Metabolism and Signaling, Protein Kinase Regulation and GTPase Signaling, Caveolin-1 and cellular processes, Intracranial Aneurysms: Treatment and Complications
Most-Cited Works
- → Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways(2008)1,037 cited
- → Evolution of Diaphragm Thickness during Mechanical Ventilation. Impact of Inspiratory Effort(2015)601 cited
- → Impaired Conduction of Vasodilation Along Arterioles in Connexin40-Deficient Mice(2000)335 cited
- → Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion(2003)200 cited
- → Deafness and Stria Vascularis Defects in S1P2 Receptor-null Mice(2007)193 cited
- → A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis(2012)167 cited